• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尼芬净纵向国际监测项目的初步结果(2003年)

Initial results from a longitudinal international surveillance programme for anidulafungin (2003).

作者信息

Messer Shawn A, Kirby Jeffrey T, Sader Helio S, Fritsche Thomas R, Jones Ronald N

机构信息

The JONES Group/JMI Laboratories, Inc., 345 Beaver Kreek Centre, Suite A, North Liberty, IA 52317, USA.

出版信息

J Antimicrob Chemother. 2004 Dec;54(6):1051-6. doi: 10.1093/jac/dkh504. Epub 2004 Nov 25.

DOI:10.1093/jac/dkh504
PMID:15564286
Abstract

OBJECTIVES

This longitudinal study evaluated the in vitro activity of anidulafungin against 880 clinical yeast isolates and 68 mould isolates from 64 medical centres in North America, Latin America and Europe.

METHODS

MICs of anidulafungin, amphotericin B, 5-fluorocytosine, fluconazole, itraconazole, ketoconazole and voriconazole were determined using reference method (M27-A2) guidelines. The M38-A reference method was used for the filamentous fungi, including determination of minimum effective concentrations (MECs) of anidulafungin.

RESULTS

Anidulafungin was more active when compared with fluconazole and itraconazole for Candida albicans (MIC(90), 0.06 mg/L), Candida tropicalis (MIC(90), 0.06 mg/L), Candida glabrata (MIC(90), 0.12 mg/L), Candida krusei (MIC(90), 0.06 mg/L) and Candida lusitaniae (MIC(90), 1 mg/L) as well as the less-often encountered yeast species. Anidulafungin was less active against Candida parapsilosis, Candida guilliermondii and Candida famata (MIC(50), 1-2 mg/L). Anidulafungin also exhibited excellent activity against all Aspergillus spp. (MEC(90), < or =0.03 mg/L). Anidulafungin was also evaluated comparing two end point reading criteria and two incubation intervals. Data indicate that longer incubation periods do not significantly influence overall MIC ranges. These international surveillance results for anidulafungin confirm the activity observed in studies of smaller numbers of isolates.

摘要

目的

这项纵向研究评估了阿尼芬净对来自北美、拉丁美洲和欧洲64个医疗中心的880株临床酵母分离株和68株霉菌分离株的体外活性。

方法

采用参考方法(M27 - A2)指南测定阿尼芬净、两性霉素B、5-氟胞嘧啶、氟康唑、伊曲康唑、酮康唑和伏立康唑的最低抑菌浓度(MIC)。丝状真菌采用M38 - A参考方法,包括测定阿尼芬净的最低有效浓度(MEC)。

结果

与氟康唑和伊曲康唑相比,阿尼芬净对白色念珠菌(MIC90,0.06mg/L)、热带念珠菌(MIC90,0.06mg/L)、光滑念珠菌(MIC90,0.12mg/L)、克柔念珠菌(MIC90,0.06mg/L)和葡萄牙念珠菌(MIC90,1mg/L)以及较少见的酵母菌种活性更强。阿尼芬净对近平滑念珠菌、季也蒙念珠菌和法塔念珠菌活性较弱(MIC50,1 - 2mg/L)。阿尼芬净对所有曲霉属菌种也表现出优异活性(MEC90,≤0.03mg/L)。还比较了阿尼芬净的两种终点读数标准和两种孵育间隔。数据表明较长的孵育期对总体MIC范围没有显著影响。这些阿尼芬净的国际监测结果证实了在较少数量分离株研究中观察到的活性。

相似文献

1
Initial results from a longitudinal international surveillance programme for anidulafungin (2003).阿尼芬净纵向国际监测项目的初步结果(2003年)
J Antimicrob Chemother. 2004 Dec;54(6):1051-6. doi: 10.1093/jac/dkh504. Epub 2004 Nov 25.
2
In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole.阿尼芬净对2500多株念珠菌临床分离株的体外活性,其中包括315株对氟康唑耐药的分离株。
J Clin Microbiol. 2005 Nov;43(11):5425-7. doi: 10.1128/JCM.43.11.5425-5427.2005.
3
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.日本念珠菌属血液分离株的物种分布及其对包括伏立康唑和米卡芬净在内的六种抗真菌药物的敏感性的全国监测。
J Antimicrob Chemother. 2004 Feb;53(2):283-9. doi: 10.1093/jac/dkh053. Epub 2003 Dec 19.
4
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.通过美国国家临床实验室标准委员会(NCCLS)方法测定的阿尼芬净、米卡芬净(已获许可的药物)及研究性三唑类药物泊沙康唑对12052株真菌分离株的体外抗真菌活性:文献综述
Rev Iberoam Micol. 2003 Dec;20(4):121-36.
5
Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution method.棘白菌素类药物阿尼芬净(VER002,LY-303366)对酵母病原体的抗真菌活性:采用M27-A微量稀释法的比较研究。
J Antimicrob Chemother. 2003 Jan;51(1):163-6. doi: 10.1093/jac/dkg018.
6
Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).念珠菌血流感染:重症监护病房(ICU)和非 ICU 环境下 SENTRY 抗菌监测计划(2008-2009 年)中,菌种分布和棘白菌素类及唑类抗真菌药物耐药性的比较。
Int J Antimicrob Agents. 2011 Jul;38(1):65-9. doi: 10.1016/j.ijantimicag.2011.02.016. Epub 2011 Apr 22.
7
In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.使用Etest对念珠菌和曲霉属进行伏立康唑及其他抗真菌药物的体外药敏试验:一项法国多中心研究的结果
Int J Antimicrob Agents. 2005 Apr;25(4):321-8. doi: 10.1016/j.ijantimicag.2004.11.010.
8
Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.念珠菌属对氟康唑耐药的临床分离株对棘白菌素LY303366、伊曲康唑和两性霉素B的敏感性。
J Antimicrob Chemother. 2000 Sep;46(3):475-7. doi: 10.1093/jac/46.3.475.
9
Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.米卡芬净对315株耐氟康唑侵袭性念珠菌临床分离株的活性
J Clin Microbiol. 2006 Feb;44(2):324-6. doi: 10.1128/JCM.44.2.324-326.2006.
10
Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.米卡芬净对从日本儿科患者中分离出的念珠菌和曲霉菌的抗真菌活性。
Med Mycol. 2009 Mar;47(2):145-8. doi: 10.1080/13693780802262123. Epub 2008 Jul 30.

引用本文的文献

1
Meyerozyma guilliermondii species complex: review of current epidemiology, antifungal resistance, and mechanisms.梅伊罗泽姆酵母种复合体:当前流行病学、抗真菌耐药性和机制的综述。
Braz J Microbiol. 2022 Dec;53(4):1761-1779. doi: 10.1007/s42770-022-00813-2. Epub 2022 Oct 28.
2
Community acquired fungemia caused by Candida pulcherrima: diagnostic contribution of MALDI-TOF mass spectrometry.近平滑念珠菌引起的社区获得性真菌血症:基质辅助激光解吸电离飞行时间质谱的诊断作用
Ann Clin Microbiol Antimicrob. 2016 Mar 8;15:14. doi: 10.1186/s12941-016-0129-1.
3
Yeast identification algorithm based on use of the Vitek MS system selectively supplemented with ribosomal DNA sequencing: proposal of a reference assay for invasive fungal surveillance programs in China.
基于 Vitek MS 系统使用和核糖体 DNA 测序的酵母鉴定算法:中国侵袭性真菌监测计划的参考检测建议。
J Clin Microbiol. 2014 Feb;52(2):572-7. doi: 10.1128/JCM.02543-13. Epub 2013 Dec 11.
4
Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.2010 年至 2011 年收集的临床机会性酵母和霉菌分离株的棘白菌素和三唑类抗真菌药敏谱:应用新的 CLSI 临床折点和流行病学临界值来描述抗真菌耐药性的地理和时间趋势。
J Clin Microbiol. 2013 Aug;51(8):2571-81. doi: 10.1128/JCM.00308-13. Epub 2013 May 29.
5
Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: results from the global SENTRY Antimicrobial Surveillance Program (2008).比较了棘白菌素类药物(阿尼芬净)与其他 9 种抗真菌药物对念珠菌属、隐球菌属和曲霉菌属的体外抗菌活性:全球 SENTRY 抗菌药物监测计划(2008 年)的结果。
J Clin Microbiol. 2010 Aug;48(8):2984-7. doi: 10.1128/JCM.00328-10. Epub 2010 Jun 9.
6
In vitro activity of anidulafungin and other agents against esophageal candidiasis-associated isolates from a phase 3 clinical trial.体外活性研究:棘白菌素类药物与其他药物对 3 期临床试验中食管念珠菌病相关分离株的作用。
J Clin Microbiol. 2010 Jul;48(7):2613-4. doi: 10.1128/JCM.00806-10. Epub 2010 May 26.
7
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.ARTEMIS DISK 全球抗真菌监测研究结果,1997 年至 2007 年:10.5 年时间内通过 CLSI 标准化纸片扩散法测定的念珠菌属对氟康唑和伏立康唑的药敏性分析。
J Clin Microbiol. 2010 Apr;48(4):1366-77. doi: 10.1128/JCM.02117-09. Epub 2010 Feb 17.
8
Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007).当代抗真菌药物(包括新型棘白菌素阿尼芬净)对念珠菌属、隐球菌属和曲霉属的活性:哨兵抗菌监测计划(2006年至2007年)报告
J Clin Microbiol. 2009 Jun;47(6):1942-6. doi: 10.1128/JCM.02434-08. Epub 2009 Apr 22.
9
Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi.在对丝状真菌进行阿尼芬净药敏试验中,将纸片扩散法与微量稀释法进行比较的评估。
J Clin Microbiol. 2008 Dec;46(12):4071-4. doi: 10.1128/JCM.01088-08. Epub 2008 Oct 15.
10
In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera.阿尼芬净和卡泊芬净对光滑念珠菌的体内疗效以及在血清存在下与体外效力的相关性。
Antimicrob Agents Chemother. 2007 May;51(5):1616-20. doi: 10.1128/AAC.00105-07. Epub 2007 Feb 16.